RIPE-KG · Version 1.1.0 · Resource

ripekg:retraction-notice/21506

https://w3id.org/ripe/ripe-kg/retraction-notice/21506

Subject	Predicate	Object
`ripekg:evaluation/RIPEA02C7C24523188961`	`prov:used`	`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients
`ripekg:evaluation/RIPEA6DBDE4E81DF5F0FA`	`prov:used`	`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`prism:doi`	10.1016/j.jstrokecerebrovasdis.2019.104426
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`prism:publicationDate`	2019-10-24
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`prism:publicationName`	Journal of Stroke and Cerebrovascular Disease
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`dcterms:publisher`	`ripekg:publisher/RIPEP89ABFFE2696381B7`Elsevier
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`dcterms:title`	An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`http://purl.org/spar/cito/retracts`	`ripekg:work/10.1016%2Fj.jstrokecerebrovasdis.2009.10.007`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`rdf:type`	`http://purl.org/spar/fabio/RetractionNotice`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`rdf:type`	`rdfs:Resource`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`rdf:type`	`owl:Thing`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`rdf:type`	`ripe:IntegrityAssessmentEvidence`Integrity assessment evidence
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`rdf:type`	`ripe:RetractionNotice`Retraction notice
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`rdf:type`	`tido:Evidence`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`rdf:type`	`tido:PieceOfInformation`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`owl:sameAs`	`https://semopenalex.org/work/W4205159170`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`prov:wasAttributedTo`	`ripekg:source/retraction-watch`Retraction Watch
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`prov:wasAttributedTo`	`ripekg:source/retraction-watch`Retraction Watch Database
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`prov:wasGeneratedBy`	`ripekg:evidence-aggregation/RIPEA02C7C24523188961`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`prov:wasGeneratedBy`	`ripekg:evidence-aggregation/RIPEA6DBDE4E81DF5F0FA`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`prov:wasMemberOf`	`ripekg:research-integrity-assessment/RIPEA02C7C24523188961`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`prov:wasMemberOf`	`ripekg:research-integrity-assessment/RIPEA6DBDE4E81DF5F0FA`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`ripe:concerns`	`ripekg:author/RIPEAUF67B00FC408ABCD5`Yoshiaki Honda
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`ripe:concerns`	`ripekg:work/10.1016%2Fj.jstrokecerebrovasdis.2009.10.007`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`ripe:rationale`	Concerns/Issues About Authorship/Affiliation;Duplication of/in Article;Error in Data;Investigation by Company/Institution;Investigation by Journal/Publisher;Misconduct - Official Investigation(s) and/or Finding(s);Misconduct by Author;Unreliable Data;Unreliable Image;Unreliable Results and/or Conclusions
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`ripe:retractionWatchRecordId`	21506
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`tido:supports`	`ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-human-1-3`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`tido:supports`	`ripekg:integrity-assessment-hypothesis/RIPEA02C7C24523188961-inspectai-1-3`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`tido:supports`	`ripekg:integrity-assessment-hypothesis/RIPEA6DBDE4E81DF5F0FA-human-1-1`
`ripekg:retraction-notice/21506`An Open-Label Trial Comparing Alendronate and Alphacalcidol in Reducing Falls and Hip Fractures in Disabled Stroke Patients	`tido:supports`	`ripekg:integrity-assessment-hypothesis/RIPEA6DBDE4E81DF5F0FA-inspectai-1-1`